LITTLE ROCK, Ark. (AP) — Arkansas' capital city pre-emptively broke up with Amazon Thursday rather than submit a long-shot bid for the e-commerce giant's second headquarters, telling the company in a full-page newspaper ad: "It's not you, it's us."The Seattle-based tech giant set off a nationwide race for its business last month with a call for bids, and Little Rock Mayor Mark Stodola had said his city would pursue the project. But on Thursday, the Little Rock Regional Chamber of Commerce ran a full-page ad in the Washington Post — which is owned by Amazon CEO Jeff Bezos — explaining why it wasn't pursuing the project after all.
NYS Entity Status
NYS Filing Date
AUGUST 05, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - CONVERGING CAPITAL, LLC
Around the Web
- Little Rock drops Amazon bid in ad: 'It's not you, it's us.'
By ANDREW DeMILLO, Associated Press - Thursday Oct 19, 2017
- Marches for Racial Justice and Black Women Converge in Washington
By EMILY BAUMGAERTNER - Saturday Sep 30, 2017
Thousands of demonstrators proved that the summer of protests in the capital had not yet come to a close.
- Weinstein Company Agrees to a Rescue Investment From Colony Capital
By MICHAEL J. de la MERCED - Monday Oct 16, 2017
The Weinstein Company, reeling from scandals surrounding Harvey Weinstein, said on Monday that it had agreed to a financial lifeline from Colony Capital.
- Shareholders Demand More Drastic Shifts at Nestlé
By STEPHANIE STROM - Tuesday Jun 27, 2017
The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.
- Start-Up Bets on Tech Talent Pipeline From Africa
By STEVE LOHR - Tuesday Oct 10, 2017
Andela, which has attracted the attention and money of people like Mark Zuckerberg, trains and employs workers in Africa to do programming.
- What Steps Should NY Biotech Take in 2018? Share Your View on Dec. 11
By Ben Fidler - Monday Nov 20, 2017
Change takes time. Particularly in the life sciences, where a single drug’s journey from idea to market can consist of more than a decade of small, yet critical steps. For New York, then, aspirations to become a region known for its biotech industry are—and always have been—a long game in which every year and bit […]